Physical Performance, Rhabdomyolysis
Conditions
Brief summary
In order to examine the effect of RIPC on skeleton muscle exertional damage and on aerobic and anaerobic physical performances, 30 healthy volunteers will undergo a series of different physical tests twice; once without intervention and a second time with RIPC intervention or placebo (false) intervention.
Detailed description
30 healthy civilians volunteers will be recruited and divided randomly into 2 groups: RIPC group and control group. The experiment protocol consist 2 series (with a month between them), both series include the described 3 days: Day 1 - anthropometry measurements and VO2max test (BRUCE protocol). Day 2 - steps test (heled protocol). Day 3 - anaerobic test (wingate protocol), 1 hour rest and time to exhaustion test (heled protocol). The first series will be performed without applying any intervention and is considered as baseline measurements for both groups. the second series will be performed as follows: a. RIPC group: applying RIPC exposure (placing a sphygmomanometer on the non-dominant hand and applying pressure of 200 mmHg for 5 min followed by 5 min without pressure X 4 repeats) at the beginning of every meeting. b. control group: with placebo (false) exposure (placing a sphygmomanometer on the non-dominant hand and applying pressure of 100 mmHg for 5 min followed by 5 min without pressure X 4 repeats) at the beginning of every meeting. Blood ample, lactic acid and urine sample will be tested at the beginning and end of every meeting (testing for muscle, skeleton and kidney function markers).
Interventions
PROCEDURERIPC intervention exposure
placing a sphygmomanometer on the non-dominant hand and applying pressure of 200 mmHg for 5 min followed by 5 min without pressure X 4 repeats
PROCEDUREplacebo intervention exposure
placing a sphygmomanometer on the non-dominant hand and applying pressure of 100 mmHg for 5 min followed by 5 min without pressure X 4 repeats.
Sponsors
Sheba Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes
Inclusion criteria
* aged 18-30 * healthy civilians volunteers * with no background illnesses * above average fitness
Exclusion criteria
* known chronic medical illness * routine medication usage * history of rhabdomyolysis * the physician decision
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| creatine phosphokinase (CPK) | 6 experiment days for each participant | CPK is a marker for muscle damage assessed in blood test. blood sample will be taken before and after step test, anaerobic test and time to exhaustion test. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| heart rate variability (HRV) | 6 experiment days for each participant | HRV will be measured using a wearable heart rate monitor (Polar® sensor and heart rate monitor watch) at rest for 10 min, before and after RIPC. data will be analysed by an expert. |
| lactic acid | 6 experiment days for each participant | lactic acid level is assessed from blood drop (finger sting), will be taken before and after every test. lactic acid is a marker for anaerobic effort evaluating. |
| blood count | 6 experiment days for each participant | blood counts are done to monitor overall health and to confirm a diagnosis of some medical conditions. |
| oxygen consumption (VO2) | 6 experiment days for each participant | VO2 will be monitored continuously using a metabolic system (ERGOTEST 680, ZAN, GERMANY ) during VO2max test and time to exhaustion test |
| renal function (composite) | 6 experiment days for each participant | renal function (in order or not) will be evaluated from two markers measured in blood sample (chemistry): creatinine and urea. |
| inflammation (composite) | 6 experiment days for each participant | C-reactive protein (CRP) and blood sedimentation rate (assessed from blood sample) are indicators for inflammation. |
| heart rate | 6 experiment days for each participant | HR will be monitored during the physical tests using a wearable heart rate monitor (Polar® sensor and heart rate monitor watch). |
| apolipoprotein A1 (APO-A1) levels | 6 experiment days for each participant | APO-A1 is measured in blood chemistry as a marker for cholesterol. |
Countries
Israel
Contacts
Primary ContactOfir Frenkel, M.D
Outcome results
None listed